Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; removed entries for Multiple myeloma, related topics, MedlinePlus Genetics, and Revision: v3.5.0.
    Difference
    0.2%
    Check dated 2026-04-17T02:17:34.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    UI/layout adjustments are visible, with some sections duplicated likely due to rendering. No new or removed critical trial details (eligibility criteria, outcomes, or study purpose) are evident in the changes.
    Difference
    0.1%
    Check dated 2026-04-02T14:47:46.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Removed references to 'Multiple Myeloma' and to 'MedlinePlus Genetics' from the page's related topics. This reduces explicit disease context and cross-links that help users discover and understand the study.
    Difference
    0.2%
    Check dated 2026-03-26T03:29:18.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added related topics for Multiple myeloma and MedlinePlus Genetics, and updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T22:50:51.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site footer revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T20:08:02.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Removed the 'Multiple myeloma' condition and the related topic 'MedlinePlus Genetics' from the page.
    Difference
    0.2%
    Check dated 2026-03-04T15:25:11.000Z thumbnail image

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.